Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Huize partners with Ruihua Health to launch 'Guardian Critical Care No.5' » 05:51
06/08/22
06/08
05:51
06/08/22
05:51
HUIZ

Huize

$1.04 /

+ (+0.00%)

Huize Holding announced…

Huize Holding announced that it has partnered with Ruihua Health Assurance to launch "Guardian Critical Care No.5", a customized multiple-benefit critical illness insurance product. There are four key product highlights of "Guardian Critical Care No.5": (i) extensive coverage for 120 severe illnesses, 35 moderate illnesses and 40 mild illnesses; (ii) up to 6 claims for mild-to-severe illnesses (at least one severe illness claim) for up to 900% of the original sum assured in total; (iii) optional benefit equal to 50%/40%/30% of the original sum assured for the 1st/2nd/3rd treatment of severe malignant tumors; and (iv) optional benefit equivalent to 60% of the original sum assured for critical illnesses that occur before the age of 60.

ShowHide Related Items >><<
HUIZ Huize
$1.04 /

+ (+0.00%)

HUIZ Huize
$1.04 /

+ (+0.00%)

03/21/22 Citi
Huize price target lowered to $3.20 from $10 at Citi
Over a month ago
Hot Stocks
Huize files 2021 annual report » 09:17
04/27/22
04/27
09:17
04/27/22
09:17
HUIZ

Huize

$1.03 /

+ (+0.00%)

Huize Holding announced…

Huize Holding announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission on April 27, 2022.

ShowHide Related Items >><<
HUIZ Huize
$1.03 /

+ (+0.00%)

HUIZ Huize
$1.03 /

+ (+0.00%)

03/21/22 Citi
Huize price target lowered to $3.20 from $10 at Citi
Over a quarter ago
Recommendations
Huize price target lowered to $3.20 from $10 at Citi » 05:37
03/21/22
03/21
05:37
03/21/22
05:37
HUIZ

Huize

$1.23 /

+0.2894 (+30.77%)

Citi analyst Michelle Ma…

Citi analyst Michelle Ma lowered the firm's price target on Huize to $3.20 from $10 and keeps a Buy rating on the shares. The company reported "robust business expansion" in Q4, Ma tells investors in a research note. However, the analyst is "wary" of Huize's fiscal 2022 outlook due to tightened regulatory regimes, business transition to an O2O model and weak consumer confidence.

ShowHide Related Items >><<
HUIZ Huize
$1.23 /

+0.2894 (+30.77%)

Hot Stocks
Huize partners with Huagui Life Insurance to launch 'Da Mai Ding Hai Zhu' » 05:15
11/05/21
11/05
05:15
11/05/21
05:15
HUIZ

Huize

$2.00 /

-0.015 (-0.75%)

Huize announced that it…

Huize announced that it has partnered with Huagui Life Insurance to launch "Da Mai Ding Hai Zhu", a customized term life insurance product designed to meet the protection needs of the younger generation. There are three key product highlights of "Da Mai Ding Hai Zhu": basic coverage of up to RMB 3M with additional benefits of up to RMB 6M for major traffic accidents and events triggered by natural disasters; care benefits of up to RMB 1.5M for either parent, and special care benefits for death before 45 years old; and increased flexibility in health declaration process, lowering the threshold for consumers with pre-existing conditions.

ShowHide Related Items >><<
HUIZ Huize
$2.00 /

-0.015 (-0.75%)

Hot Stocks
Huize to acquire Shengs Life & General » 06:02
09/24/21
09/24
06:02
09/24/21
06:02
HUIZ

Huize

$2.19 /

-0.04 (-1.79%)

Huize announced that the…

Huize announced that the group, through Shenzhen Zhixuan Wealth Investment Management Co., a wholly-owned subsidiary of the group's consolidated variable interest entity, has entered into a definitive agreement to acquire a controlling equity interest in Hubei Shengs Life & General Insurance Agency Co., one of the regional insurance agency groups dedicated to distributing life and health insurance products. Pursuant to the definitive agreement by and among Zhixuan Investment, Shengs Life & General and current shareholders of Shengs Life & General, Shengs Life & General will undergo a series of restructuring so as to become a wholly-owned subsidiary of a group company. Subsequently, Zhixuan Investment will acquire a total of 56.19% equity interest in Shengs Group for a share purchase price of approximately RMB42.68M in cash, together with a capital injection of RMB15M. The transaction is expected to complete by the end of 2021, subject to the satisfaction of customary conditions precedent. Following the completion of the transaction, Shengs Life & General will be accounted for as a consolidated subsidiary of the company.

ShowHide Related Items >><<
HUIZ Huize
$2.19 /

-0.04 (-1.79%)

Hot Stocks
Huize to acquire controlling interest in Hubei Shengs Life & General » 18:01
08/24/21
08/24
18:01
08/24/21
18:01
HUIZ

Huize

$2.67 /

+0.115 (+4.50%)

Huize Holding announced…

Huize Holding announced that the Group has entered into a binding memorandum of understanding to acquire a controlling equity interest in Hubei Shengs Life & General Insurance Agency, "one of the leading regional insurance agency groups dedicated to distributing life and health insurance products."

ShowHide Related Items >><<
HUIZ Huize
$2.67 /

+0.115 (+4.50%)

Hot Stocks
Huize announces $5M management share purchase plan » 07:48
08/17/21
08/17
07:48
08/17/21
07:48
HUIZ

Huize

$2.34 /

-0.36 (-13.33%)

Huize Holding announced…

Huize Holding announced that its Board of Directors has approved the Management Share Purchase Plan, pursuant to which Mr. Cunjun Ma, the Company's Chairman of the Board and CEO, and certain other members of the Company's management team intend to allocate their personal funds to purchase up to an aggregate of $5M worth of the Company's ADSs during a six-month period following today, pursuant and subject to applicable laws and the Company's securities trading policy. The management share purchase may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. The management team has agreed to be subject to lock-up restrictions for a period of six months with respect to the proposed purchased shares.

ShowHide Related Items >><<
HUIZ Huize
$2.34 /

-0.36 (-13.33%)

Hot Stocks
Huize partners with Sungrow to launch cryopreservation service » 06:16
07/13/21
07/13
06:16
07/13/21
06:16
HUIZ

Huize

$5.15 /

-0.115 (-2.18%)

Huize Holding announced…

Huize Holding announced that it has partnered with Sungrow to launch immune cell cryopreservation as a value-added healthcare service for eligible insurance customers. The immune cell cryopreservation technology is supported by BGI Cell, and refers to the use of advanced biotechnology to extract immune cells from a healthy human body to be preserved at temperatures below -196 degrees C. These dormant cells can be reactivated in the future and are valuable for anti-aging, tissue regeneration, immune regulation, and other disease treatments.

ShowHide Related Items >><<
HUIZ Huize
$5.15 /

-0.115 (-2.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.